In:
Infectious Diseases & Immunity, Ovid Technologies (Wolters Kluwer Health), Vol. 2, No. 3 ( 2022-06-28), p. 168-178
Abstract:
End-stage liver disease (ESLD) is a life-threatening clinical syndrome that markedly increases mortality in patients with infections. In patients with ESLD, infections can induce or aggravate the occurrence of liver decompensation. Consequently, infections are among the most common complications of disease progression. There is a lack of working procedure for early diagnosis and appropriate management for patients with ESLD complicated by infections as well as local and international guidelines or consensus. This consensus assembled up-to-date knowledge and experience across Chinese colleagues, providing data on principles as well as working procedures for the diagnosis and treatment of patients with ESLD complicated by infections.
Type of Medium:
Online Resource
ISSN:
2693-8839
DOI:
10.1097/ID9.0000000000000055
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2022
detail.hit.zdb_id:
3123817-8